Oramed Pharmaceuticals Inc — Quarterly Financial Data (NASDAQ:ORMP) | MetaTrader

Open full chart

Financials

Overview Rapor Statistics Dividends

Quarterly Annual

Dividends per share ————— — Dividend yield % ————— — Payout ratio % ————— —

Oramed Pharmaceuticals Inc

Oramed Pharmaceuticals Inc., is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.

Haberler

Oramed, oral ilaç dağıtım platformunu Lifeward’a devredecek

Lifeward, 47 milyon dolarlık anlaşmayla Oramed’in oral protein iletim teknolojisini satın alacak

Oramed hisseleri Scilex’ten 18 milyon dolar ödeme aldıktan sonra yükseldi

Oramed stock rises after receiving $18 million payment from Scilex

Oramed receives $18 million payment from Scilex, declares dividend

Oramed Pharmaceuticals yöneticisi Leonard Sank 18 yıl sonra istifa edecek

Oramed Pharmaceuticals director Leonard Sank to resign after 18 years

Oramed Pharmaceuticals, Scilex’ten 28,5 milyon dolarlık hisse alım hakkını geri satın aldı

Oramed Pharmaceuticals completes $28.5 million warrant repurchase by Scilex

Scilex Holding Co 12,7 milyon dolar değerinde hisse satışı gerçekleştirdi

Scilex Holding Co sells shares worth $12.7 million

Oramed Pharmaceuticals: Scarred, Well-Capitalized, And Regrouping After Setback